144 related articles for article (PubMed ID: 15140136)
1. alphaIIbbeta3 antagonism vs. antiadhesive treatment to prevent platelet interactions with vascular subendothelium.
Melis E; Bonnefoy A; Daenens K; Yamamoto H; Vermylen J; Hoylaerts MF
J Thromb Haemost; 2004 Jun; 2(6):993-1002. PubMed ID: 15140136
[TBL] [Abstract][Full Text] [Related]
2. Preferential antagonism of the interactions of the integrin alpha IIb beta 3 with immobilized glycoprotein ligands by snake-venom RGD (Arg-Gly-Asp) proteins. Evidence supporting a functional role for the amino acid residues flanking the tripeptide RGD in determining the inhibitory properties of snake-venom RGD proteins.
Lu X; Williams JA; Deadman JJ; Salmon GP; Kakkar VV; Wilkinson JM; Baruch D; Authi KS; Rahman S
Biochem J; 1994 Dec; 304 ( Pt 3)(Pt 3):929-36. PubMed ID: 7529494
[TBL] [Abstract][Full Text] [Related]
3. Real-time analysis of shear-dependent thrombus formation and its blockade by inhibitors of von Willebrand factor binding to platelets.
Alevriadou BR; Moake JL; Turner NA; Ruggeri ZM; Folie BJ; Phillips MD; Schreiber AB; Hrinda ME; McIntire LV
Blood; 1993 Mar; 81(5):1263-76. PubMed ID: 8443388
[TBL] [Abstract][Full Text] [Related]
4. Platelet-vessel wall interactions in thrombosis and restenosis role of von Willebrand factor.
Hoylaerts MF
Verh K Acad Geneeskd Belg; 1997; 59(3):161-83. PubMed ID: 9490916
[TBL] [Abstract][Full Text] [Related]
5. Comparative real-time effects on platelet adhesion and aggregation under flowing conditions of in vivo aspirin, heparin, and monoclonal antibody fragment against glycoprotein IIb-IIIa.
Turner NA; Moake JL; Kamat SG; Schafer AI; Kleiman NS; Jordan R; McIntire LV
Circulation; 1995 Mar; 91(5):1354-62. PubMed ID: 7867173
[TBL] [Abstract][Full Text] [Related]
6. Platelet thrombus formation on collagen at high shear rates is mediated by von Willebrand factor-glycoprotein Ib interaction and inhibited by von Willebrand factor-glycoprotein IIb/IIIa interaction.
Wu YP; Vink T; Schiphorst M; van Zanten GH; IJsseldijk MJ; de Groot PG; Sixma JJ
Arterioscler Thromb Vasc Biol; 2000 Jun; 20(6):1661-7. PubMed ID: 10845886
[TBL] [Abstract][Full Text] [Related]
7. Antagonism of the GPIIb/IIIa receptor with the nonpeptidic molecule BIBU52: inhibition of platelet aggregation in vitro and antithrombotic efficacy in vivo.
Guth BD; Seewaldt-Becker E; Himmelsbach F; Weisenberger H; Müller TH
J Cardiovasc Pharmacol; 1997 Aug; 30(2):261-72. PubMed ID: 9269956
[TBL] [Abstract][Full Text] [Related]
8. Evidence that the arg1744 gly1745 asp1746 sequence in the GPIIb-IIIa-binding domain of von Willebrand factor is involved in platelet adhesion and thrombus formation on subendothelium.
Weiss HJ; Hoffmann T; Yoshioka A; Ruggeri ZM
J Lab Clin Med; 1993 Sep; 122(3):324-32. PubMed ID: 8409708
[TBL] [Abstract][Full Text] [Related]
9. Glycoprotein Ib, von Willebrand factor, and glycoprotein IIb:IIIa are all involved in platelet adhesion to fibrin in flowing whole blood.
Hantgan RR; Hindriks G; Taylor RG; Sixma JJ; de Groot PG
Blood; 1990 Jul; 76(2):345-53. PubMed ID: 2369638
[TBL] [Abstract][Full Text] [Related]
10. Ability of different glycoprotein IIb-IIIa ligands to support platelet aggregation induced by activating antibody CRC54.
Naimushin YA; Mazurov AV
Biochemistry (Mosc); 2005 Jul; 70(7):782-9. PubMed ID: 16097942
[TBL] [Abstract][Full Text] [Related]
11. Optimal antagonism of GPIIb/IIIa favors platelet adhesion by inhibiting thrombus growth. An ex vivo capillary perfusion chamber study in the guinea pig.
André P; Arbeille B; Drouet V; Hainaud P; Bal dit Sollier C; Caen JP; Drouet LO
Arterioscler Thromb Vasc Biol; 1996 Jan; 16(1):56-63. PubMed ID: 8548427
[TBL] [Abstract][Full Text] [Related]
12. Development of monoclonal antibodies that inhibit platelet adhesion or aggregation as potential anti-thrombotic drugs.
De Meyer SF; Vanhoorelbeke K; Ulrichts H; Staelens S; Feys HB; Salles I; Fontayne A; Deckmyn H
Cardiovasc Hematol Disord Drug Targets; 2006 Sep; 6(3):191-207. PubMed ID: 17017902
[TBL] [Abstract][Full Text] [Related]
13. Platelet adhesion and thrombus formation on subendothelium in platelets deficient in glycoproteins IIb-IIIa, Ib, and storage granules.
Weiss HJ; Turitto VT; Baumgartner HR
Blood; 1986 Feb; 67(2):322-30. PubMed ID: 2935207
[TBL] [Abstract][Full Text] [Related]
14. Characterization of the novel murine monoclonal anti-von Willebrand factor (vWf) antibody GUR76-23 which inhibits vWf interaction with alpha IIb beta 3 but not alpha v beta 3 integrin.
Yokoyama K; Handa M; Oda A; Katayama M; Fujimura Y; Murata M; Kawai Y; Watanabe K; Ikeda Y
Biochem Biophys Res Commun; 1997 May; 234(1):147-52. PubMed ID: 9168979
[TBL] [Abstract][Full Text] [Related]
15. Adhesion of blood platelets is inhibited by VCL, a recombinant fragment (leucine504 to lysine728) of von Willebrand factor.
Sixma JJ; Ijsseldijk MJ; Hindriks G; van Zanten GH; Gorecki M; Panet A; Garfinkel LI; de Groot PG
Arterioscler Thromb Vasc Biol; 1996 Jan; 16(1):64-71. PubMed ID: 8548428
[TBL] [Abstract][Full Text] [Related]
16. Platelet microparticles promote platelet interaction with subendothelial matrix in a glycoprotein IIb/IIIa-dependent mechanism.
Merten M; Pakala R; Thiagarajan P; Benedict CR
Circulation; 1999 May; 99(19):2577-82. PubMed ID: 10330391
[TBL] [Abstract][Full Text] [Related]
17. Calpain regulation of cytoskeletal signaling complexes in von Willebrand factor-stimulated platelets. Distinct roles for glycoprotein Ib-V-IX and glycoprotein IIb-IIIa (integrin alphaIIbbeta3) in von Willebrand factor-induced signal transduction.
Yuan Y; Dopheide SM; Ivanidis C; Salem HH; Jackson SP
J Biol Chem; 1997 Aug; 272(35):21847-54. PubMed ID: 9268316
[TBL] [Abstract][Full Text] [Related]
18. Asialo von Willebrand factor enhances platelet adhesion to vessel subendothelium.
Bastida E; Monteagudo J; Ordinas A; De Marco L; Castillo R
Thromb Haemost; 1988 Aug; 60(1):30-4. PubMed ID: 3263711
[TBL] [Abstract][Full Text] [Related]
19. The subendothelium of the HMEC-1 cell line supports thrombus formation in the absence of von Willebrand factor and collagen types I, III and VI.
Bonnefoy A; Harsfalvi J; Pfliegler G; Fauvel-Lafève F; Legrand C
Thromb Haemost; 2001 Mar; 85(3):552-9. PubMed ID: 11307830
[TBL] [Abstract][Full Text] [Related]
20. Comparative antiplatelet efficacy of a novel, nonpeptide GPIIb/IIIa antagonist (XV454) and abciximab (c7E3) in flow models of thrombosis.
Abulencia JP; Tien N; McCarty OJ; Plymire D; Mousa SA; Konstantopoulos K
Arterioscler Thromb Vasc Biol; 2001 Jan; 21(1):149-56. PubMed ID: 11145947
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
